Tuesday, May 5, 2020

Adaptive Biotechnologies And Microsoft Launch Virtual ImmuneRACE Study

LabCorp, through its Covance drug development business, will provide a safe, in-person COVID-19 sample collection service from the convenience of patients’ homes De-identified data about immune response to COVID-19 will be made freely available to advance public health solutions.